Author/Authors :
Bolat, Fatih Cumhuriyet University - School of Medicine - Department of Neonatology, Turkey , Güven, Ahmet Sami Cumhuriyet University - School of Medicine - Department of Neurology, Turkey , Cihan, Meriç Kaymak Cumhuriyet University - School of Medicine - Department of Pediatrics, Turkey , Çoskun, Hikmet Cumhuriyet University - School of Medicine - Department of Pediatrics, Turkey , İçağasıoğlu, Füsun Dilara Cumhuriyet University - School of Medicine - Department of Neurology, Turkey
Abstract :
Levetiracetam is a novel anticonvulsant drug that was approved by the FDA in adult and pediatric convulsions. There is not sufficient information regarding the use of newborn such as the appropriate dose and interval, its safety, efficacy and adverse effects. We present a case of a 10 day-old male, who was accidentally administered 75 mg/kg/d levetiracetam for 3 days by his mother at home. The patient was discharged 4 days after admission to hospital without any signs and symptoms. The case demonstrated that high dose levetiracetam might be safe in newborn convulsions.
NaturalLanguageKeyword :
Levetiracetam , newborn , convulsion , dose , safe
